#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hypomagnesaemia Keratosis follicular Trigeminal neuralgia Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome Methylmalonic acidaemia Thrombocytopenia Hodgkin's disease refractory Congenital hypotransferrinaemia Plasma cell myeloma B precursor type acute leukaemia Alport's syndrome Netherton's syndrome Nodal marginal zone B-cell lymphoma Small intestine leiomyosarcoma Primary biliary cholangitis More trials…

    Learn about Rare Diseases

    Haemophilia A without inhibitors – Life with Disease Atypical teratoid/rhabdoid tumour of CNS – Basic Information Gaucher’s disease type I – Treatment Cystic fibrosis lung Alport’s syndrome Acquired haemophilia – Basic Information Usher’s syndrome – Basic Information Hyperoxaluria – Life with Disease Ewing’s sarcoma metastatic – Treatment Hairy cell leukaemia – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    POLYMYXIN B SULFATE Lsta1 L-Tyrosine Acetic Acid, Glacial Baclofen Emactuzumab Doxazosin Mesilate Sufentanil GVV858 Ht-29-A Nacubactam Fluvastatin Keto-Valine Calcium Savolitinib Pabinafusp Alfa Avapritinib Levobupivacaine Hydrochloride LTI-03 Glucagon R-Azasetron Besilate More therapies…

    Learn about Your Condition

    Oesophageal atresia Sjogren's syndrome Carotid artery stenosis Colorectal cancer stage IV Skin cancer Gastrointestinal disorder Delayed graft function Diabetes insipidus Onychomycosis Pleural mesothelioma Prostate cancer recurrent Limb reduction defect Inflammation Pneumococcal infection Haemodynamic instability More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Axon Clinical s.r.o.

Axon Clinical s.r.o.

Ostrovskeho 253/3, Smichov, Prague, 150 00, Czechia

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Long-Term Safety and Effects of Pegcetacoplan for Patients with Geographic Atrophy from Age-Related Macular Degeneration

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Pegcetacoplan
    Czechia France Germany Italy The Netherlands Poland +1
  • Study on Elamipretide for Patients with Dry Age-Related Macular Degeneration (Dry AMD)

    Not recruiting

    3 1
    Investigated Drugs:
    • Elamipretide Trihydrochloride
    Czechia Germany Hungary Italy Spain
  • Study of Efgartigimod for Adults with Thyroid Eye Disease

    Not recruiting

    3 1
    Investigated Drugs:
    • Efgartigimod Alfa
    Belgium Bulgaria Czechia Estonia Germany Greece +4
  • Study on the Safety and Effectiveness of MEDI0618 for Reducing Migraine Days in Adults with Episodic Migraine

    Not recruiting

    2 1
    Investigated Diseases:
    • Migraine
    Investigated Drugs:
    • Medi0618
    Czechia Denmark Germany Hungary Italy The Netherlands +2
  • Study on Atogepant for Treating Migraine in Patients: Evaluating Effectiveness and Safety

    Not recruiting

    3 1
    Investigated Diseases:
    • Migraine
    • Migraine with aura
    • Migraine without aura
    Investigated Drugs:
    • Atogepant
    Belgium Czechia Germany Hungary Italy Poland +4
  • Study on the Effectiveness and Safety of ND0612 Infusion vs. Oral Treatment for Parkinson’s Disease Patients with Motor Fluctuations

    Not recruiting

    3 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • Carbidopa
    • Levodopa
    Austria Belgium Czechia France Italy Poland +3
  • Study on the Effectiveness and Safety of OCS-01 Eye Drops with Dexamethasone for Patients with Diabetic Macular Edema

    Not recruiting

    3 1
    Investigated Diseases:
    • Diabetic retinal oedema
    Investigated Drugs:
    • Dexamethasone
    Bulgaria Czechia France Germany Italy Spain
  • Study of Danicopan for Patients with Geographic Atrophy Due to Age-Related Macular Degeneration

    Not recruiting

    2 1
    Investigated Diseases:
    • Dry age-related macular degeneration
    Investigated Drugs:
    • Danicopan
    Czechia France Germany Hungary Italy Latvia +2
  • Study on the Effectiveness and Safety of Guselkumab for Patients with Moderate to Severe Ulcerative Colitis

    Not recruiting

    3 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Guselkumab
    Belgium Bulgaria Czechia France Germany Hungary +3
  • Study on the Long-Term Safety of Tavapadon for Patients with Parkinson’s Disease

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • Tavapadon
    Bulgaria Czechia France Germany Hungary Italy +2
Previous Page
1 2 3 4 5
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!